6 November 2020
Renovo Care Group, which provides assessment, treatment and rehabilitation for adults with neurological conditions, has appointed Professor Anbananden Soopramanien MD, PhD, FRCP as group medical director.
Professor Soopramanien has a number of key responsibilities including contributing to the strategic development of the Group’s health and care business plans, providing professional medical advice to the Board of Directors and professional leadership to the medical teams across its two hospital sites.
He will also hold the position of group director of infection prevention and control and as the Caldicott Guardian, responsible for protecting the confidentiality of people’s health and care information and ensuring it is used correctly.
Professor Soopramanien is a consultant in spinal injuries and rehabilitation medicine and has worked in the UK and internationally in some of Europe’s most renowned specialist spinal rehabilitation centres including Stoke Mandeville Hospital, Centre de Readaptation de Coubert in Paris and the Royal Buckinghamshire Hospital in Aylesbury.
Although now retired as an NHS consultant, his last post was at the Spinal Centre, Salisbury NHS Foundation Trust and he still holds practising privileges with Spire Hospital in Hertfordshire and New Hall Hospital in Salisbury, Wiltshire.
Professor Soopramanien has also welcomed opportunities to become involved in international activities and charity work and currently acts as Chair for the Affiliated Societies and Networks (ASN) of the International Spinal Cord Society (ISCOS). He has also made a commitment to specifically address the problems faced by patients requiring rehabilitation for neurological conditions in his native Mauritius.
He said: “My ethos is that high quality of care, well-trained staff and active research should be our drivers at Renovo Care and that will be one of my key focuses.
“I want our hospitals to become leaders in neurological rehabilitation nationally and internationally and to develop a culture of teaching and research.
“Renovo Care must also reach out to people in the community with long-term needs such as stroke or long Covid.
“There will be challenges ahead I am sure but I am very much looking forward to working with the group chief operating officer to provide leadership for clinical governance and disseminate best practice to promote a climate that delivers clinical audit, learning and research to support continuous improvement of service.”
Phillip Smith, Group CEO, said: “I am pleased to welcome Professor Anbananden Soopramanien to the team here at Renovo Care, he is a leader in his field and I know that his knowledge and professionalism will be an asset to the Group.
“His appointment reinforces our vision to be recognised as the leading provider of neurorehabilitation services to the communities we serve by consistently providing high quality care that promotes and supports the best rehabilitative care outcomes possible.”